Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03631836
Title Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma (MARELLE01)
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Assistance Publique Hopitaux De Marseille



Andecaliximab + Bevacizumab

Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST